カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

マイクロバイオームシーケンスサービスの世界市場予測（～2028年）：サービス別、種類別、技術別、エンドユーザー別

◆英語タイトル：Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028

MarketsandMarketsが発行した調査報告書（BT5306-23）◆商品コード：BT5306-23
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2023年5月17日
◆ページ数：193
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

MarketsandMarkets社の本調査レポートでは、世界のマイクロバイオームシーケンスサービス市場規模が2023年の284百万ドルから2028年までに555ドル百万ドルに拡大し、予測期間中に年平均14.3%で成長すると予想しています。本書では、マイクロバイオームシーケンスサービスの世界市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報、隣接・関連市場などの内容を掲載しています。また、参入企業情報として、Charles River Laboratories（US）、Eurofins Scientific（France）、BGI（China）、CosmosID（US）、Microba（Australia）、QIAGEN（Germany）などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のマイクロバイオームシーケンスサービス市場規模：サービス別
- サンプル調製の市場規模
- シーケンス・ライブラリー調製の市場規模
- データ解析の市場規模
・世界のマイクロバイオームシーケンスサービス市場規模：種類別
- アンプリコンシーケンスの市場規模
- 全ゲノムシーケンスの市場規模
- ショットガンシーケンスの市場規模
- その他種類の市場規模
・世界のマイクロバイオームシーケンスサービス市場規模：技術別
- 合成型シーケンスにおける市場規模
- ライゲーションシーケンにおける市場規模
- ナノポアシーケンスにおける市場規模
・世界のマイクロバイオームシーケンスサービス市場規模：地域別
- 北米のマイクロバイオームシーケンスサービス市場規模
- ヨーロッパのマイクロバイオームシーケンスサービス市場規模
- アジア太平洋のマイクロバイオームシーケンスサービス市場規模
- 中南米のマイクロバイオームシーケンスサービス市場規模
- 中東・アフリカのマイクロバイオームシーケンスサービス市場規模
・競争状況
・企業情報
・隣接・関連市場

“マイクロバイオームシーケンスサービス市場は、2023年の2億8400万米ドルから2028年には年平均成長率14.3%で5億5500万米ドルに成長すると予測”
マイクロバイオームシーケンスサービスは研究以外の用途にも広がりつつあり、皮膚マイクロバイオームの研究や口腔マイクロバイオームシーケンスサービスなど、治療薬開発への活用が進んでいます。これらのアプリケーションは、健康と疾患における微生物叢の役割の理解を進め、皮膚の健康と口腔の健康を改善するための標的介入の開発に情報を提供する可能性があります。

“予測期間中、シーケンスおよびライブラリー調製セグメントで最も高い成長がみられる”
サービスに基づいて、マイクロバイオームシーケンスサービス市場は、サンプル調製サービス、シーケンスおよびライブラリ調製サービス、データ解析サービスに区分されます。マイクロバイオームシーケンスおよびライブラリ調製では、16S rRNAシーケンス、ショットガンメタゲノミクス、qPCR検査、短鎖脂肪酸（SCFA）分析など、さまざまなアプローチが採用されています。16S rRNAシーケンスに対する高い需要が、このセグメントの成長を後押しする見込みです。

“合成によるシーケンス（SBS）セグメントは、2022年の世界のマイクロバイオームシーケンスサービス市場で45％の最大シェアを占めた”
技術に基づいて、世界のマイクロバイオームシーケンスサービス市場は、合成によるシーケンス（SBS）、ライゲーションによるシーケンス（SBL）、ナノポアシーケンス、およびその他の技術にセグメント化されます。SBS技術は、4つの蛍光標識ヌクレオチドを使用して、フローセル表面上の数百万のクラスターを並行してシーケンスします。

“アジア太平洋地域は予測期間中に最も高いCAGRを記録すると推定”
マイクロバイオームシーケンスサービス市場は、北米、欧州、アジア太平洋（APAC）、中南米、中東・アフリカ（MEA）に区分されます。アジア太平洋地域は、健康と疾患におけるマイクロバイオームの重要性に対する認識の高まり、個別化医療に対する需要の高まり、シーケンス技術の進歩により、マイクロバイオームシーケンスサービス市場において最も急成長することが予想されます。
 
供給側の一次インタビューの内訳（企業タイプ別、役職別、地域別）
– 回答者別 供給側 (70%) , 需要側 (30%)
– 役職別 マネージャーレベル（45%）、CXOおよびディレクターレベル（35%）、エグゼクティブ（25％）
– 地域別 北米(20%)、欧州(10%)、アジア太平洋(55%)、中南米(10%)、中東アフリカ(5%)

レポート掲載企業一覧
• Charles River Laboratories (US)
• Eurofins Scientific (France)
• BGI (China)
• CosmosID (US)
• Microba (Australia)
• QIAGEN (Germany)
• Microbiome Insights (Canada)
• BaseClear (Netherlands)
• CD Genomics (US)
• Zymo Research (US)
• OraSure Technologies (US)
• MR DNA (US)
• Eremid Genomic Services (US)
• Clinical-Microbiomics A/S (Denmark)
• Novogene Co., Ltd. (China)
• EzBiome (US)
• Boster Biological Technology (US)
• Zifo (India)
• omics2view.consulting GbR (Germany)
• Macrogen, Inc. (South Korea)

調査範囲
この調査レポートは、マイクロバイオームシーケンスサービス市場をサービス、タイプ、技術、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。また、マイクロ市場についても、その成長動向、展望、マイクロバイオームシーケンスサービス市場全体への貢献に関して調査しています。レポートでは、主要5地域に関して市場セグメントの収益を予測しています。

レポートを購入する理由
本レポートは以下のポイントに関する洞察を提供します：

– マイクロバイオームシーケンスサービス市場の成長に影響を与える主な促進要因（メタゲノム解析の需要増加、ヒトマイクロバイオーム治療薬開発への注目の高まり、解析のための高度なインフラの高コスト）、阻害要因（熟練した人材の不足）、機会（治療薬開発におけるマイクロバイオームシーケンスの応用拡大）、課題（解析のためのサンプル調製/微生物の分離に関する問題）分析。
– サービスの開発／革新： 新たに開始されたサービスに関する詳細な洞察、マイクロバイオームシーケンスサービス市場の技術評価。
– 市場開発： 有利な市場に関する包括的な情報 – 当レポートでは、さまざまな地域のマイクロバイオームシーケンスサービス市場を分析しています。
– 市場の多様化： マイクロバイオームシーケンスサービス市場における新サービス、未開拓の地域、最近の開発、投資に関する網羅的な情報。
– 競合評価： マイクロバイオームシーケンスサービス市場におけるCharles River Laboratories International, Inc. (US), Eurofins Scientific (France), BGI (China)などの主要企業の市場シェア、成長戦略、サービス内容を詳細に評価。また、本レポートは、関係者がマイクロバイオームシーケンスサービス市場動向を理解するのに役立ち、主要な市場促進要因、阻害要因、課題、機会に関する情報を提供。

❖ レポートの目次 ❖

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.2.1 INCLUSIONS AND EXCLUSIONS 30
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 YEARS CONSIDERED 31
1.4 CURRENCY 31
1.5 LIMITATIONS 31
1.6 STAKEHOLDERS 32
1.7 SUMMARY OF CHANGES 32
1.7.1 RECESSION IMPACT 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 1 RESEARCH DESIGN 34
2.1.1 SECONDARY DATA 35
2.1.2 PRIMARY DATA 36
FIGURE 2 MICROBIOME SEQUENCING SERVICES MARKET: BREAKDOWN OF PRIMARIES 36
2.2 MARKET ESTIMATION METHODOLOGY 37
FIGURE 3 MICROBIOME SEQUENCING SERVICES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 37
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2022 38
FIGURE 5 ILLUSTRATIVE EXAMPLE OF COMPANY REVENUE ANALYSIS, 2022 39
2.2.1 INSIGHTS FROM PRIMARY EXPERTS 40
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 40
2.3 MARKET GROWTH RATE PROJECTIONS 41
FIGURE 7 MICROBIOME SEQUENCING SERVICES MARKET (SUPPLY-SIDE): CAGR PROJECTIONS 41
FIGURE 8 MICROBIOME SEQUENCING SERVICES MARKET: GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS 42
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 43
FIGURE 9 DATA TRIANGULATION METHODOLOGY 43
2.5 RESEARCH ASSUMPTIONS 44
2.6 RISK ANALYSIS 44
2.7 IMPACT OF RECESSION ON MICROBIOME SEQUENCING SERVICES MARKET 44
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 45
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 45
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 45
3 EXECUTIVE SUMMARY 46
FIGURE 10 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION) 46
FIGURE 11 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 12 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 47
FIGURE 13 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 48
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MICROBIOME SEQUENCING SERVICES MARKET 49
4 PREMIUM INSIGHTS 50
4.1 MICROBIOME SEQUENCING SERVICES MARKET OVERVIEW 50
FIGURE 15 GROWING FOCUS ON HUMAN MICROBIOME THERAPEUTICS DEVELOPMENT TO DRIVE MARKET 50
4.2 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE AND COUNTRY (2023) 51
FIGURE 16 SEQUENCING AND LIBRARY PREPARATION SERVICES TO ACCOUNT FOR LARGEST SHARE OF NORTH AMERICAN MICROBIOME SEQUENCING SERVICES MARKET IN 2023 51
4.3 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 51
FIGURE 17 SHOTGUN SEQUENCING SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 18 MICROBIOME SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
TABLE 4 MICROBIOME SEQUENCING SERVICES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 DRIVERS 53
5.2.1.1 Increasing demand for metagenomic sequencing 53
5.2.1.2 Growing focus on human microbiome therapeutics development 54
FIGURE 19 ROLE OF MICROBIOME SEQUENCING IN THERAPEUTICS DEVELOPMENT 54
5.2.1.3 High cost of advanced infrastructure for sequencing 55
TABLE 5 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2021) 55
5.2.2 RESTRAINTS 56
5.2.2.1 Dearth of skilled personnel 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Expanding applications of microbiome sequencing in therapeutics development 56
5.2.4 CHALLENGES 57
5.2.4.1 Issues related to sample preparation/isolation of microbes for sequencing 57
5.3 TECHNOLOGY ANALYSIS 57
5.4 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 59
FIGURE 20 REVENUE SHIFT AND NEW REVENUE POCKETS FOR MICROBIOME SEQUENCING SERVICE PROVIDERS 59
5.5 VALUE CHAIN ANALYSIS 60
FIGURE 21 VALUE CHAIN ANALYSIS OF MICROBIOME SEQUENCING SERVICES MARKET 60
5.6 ECOSYSTEM MARKET MAP 61
FIGURE 22 ECOSYSTEM OF MICROBIOME SEQUENCING SERVICES MARKET 61
5.7 PORTER’S FIVE FORCES ANALYSIS 61
TABLE 6 MICROBIOME SEQUENCING SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 61
5.7.1 THREAT OF NEW ENTRANTS 61
5.7.2 THREAT OF SUBSTITUTES 61
5.7.3 BARGAINING POWER OF SUPPLIERS 61
5.7.4 BARGAINING POWER OF BUYERS 62
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 62
5.8 REGULATORY ANALYSIS 62
5.8.1 NORTH AMERICA 62
5.8.1.1 US 62
TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION 63
TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 63
5.8.1.2 Canada 63
5.8.2 EUROPE 64
5.8.3 ASIA PACIFIC 65
5.8.3.1 China 65
TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 65
5.8.3.2 Japan 65
5.8.3.3 India 66
5.8.4 LATIN AMERICA 66
5.8.5 MIDDLE EAST 66
5.8.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 10 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS: GENOMICS, MICROBIOME RESEARCH, AND METAGENOMICS 67
5.9 PRICING ANALYSIS 68
TABLE 11 AVERAGE SELLING PRICE, BY SERVICE AND TYPE 68
5.9.1 AVERAGE SELLING PRICE TREND ANALYSIS 69
5.10 KEY CONFERENCES AND EVENTS IN 2023–2024 70
TABLE 12 MICROBIOME SEQUENCING/METAGENOMIC SEQUENCING/NGS CONFERENCES, 2023–2024 70
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 72
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF SEQUENCING SERVICES 72
FIGURE 24 CRITERIA FOR OUTSOURCING SEQUENCING SERVICES 72
6 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE 73
6.1 INTRODUCTION 74
TABLE 13 MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 74
6.2 SAMPLE PREPARATION 74
6.2.1 NEED FOR SPECIFIC SAMPLE PREPARATION PROTOCOLS BASED ON SAMPLE TYPE TO DRIVE GROWTH 74
TABLE 14 MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY REGION, 2021–2028 (USD MILLION) 75
TABLE 15 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 16 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 75
TABLE 17 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 76
TABLE 18 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 76
6.3 SEQUENCING AND LIBRARY PREPARATION 76
6.3.1 SEQUENCING AND LIBRARY PREPARATION SERVICES TO DOMINATE MARKET DURING FORECAST PERIOD 76
TABLE 19 MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 20 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 21 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 22 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 23 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SEQUENCING AND LIBRARY PREPARATION, BY COUNTRY, 2021–2028 (USD MILLION) 78
6.4 DATA ANALYSIS 78
6.4.1 DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO DRIVE GROWTH 78
TABLE 24 MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY REGION, 2021–2028 (USD MILLION) 79
TABLE 25 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 26 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 27 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 28 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR DATA ANALYSIS, BY COUNTRY, 2021–2028 (USD MILLION) 80
7 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE 81
7.1 INTRODUCTION 82
TABLE 29 MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 82
7.2 AMPLICON SEQUENCING 82
7.2.1 HIGH ACCURACY OF 16S AMPLICON SEQUENCING TO DRIVE ADOPTION 82
TABLE 30 AMPLICON SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 83
TABLE 31 NORTH AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 32 EUROPE: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 33 ASIA PACIFIC: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 34 LATIN AMERICA: AMPLICON SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
7.3 WHOLE-GENOME SEQUENCING 84
7.3.1 ACCURATE REFERENCE GENOMES GENERATED FOR MICROBIAL IDENTIFICATION TO BOOST MARKET 84
TABLE 35 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 36 NORTH AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 37 EUROPE: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 38 ASIA PACIFIC: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
TABLE 39 LATIN AMERICA: WHOLE-GENOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
7.4 SHOTGUN SEQUENCING 86
7.4.1 ADVANCEMENTS IN DATA ANALYSIS SOLUTIONS TO SUPPORT ADOPTION 86
TABLE 40 SHOTGUN SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 41 NORTH AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 42 EUROPE: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 43 ASIA PACIFIC: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 44 LATIN AMERICA: SHOTGUN SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
7.5 OTHER TYPES 89
TABLE 45 OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 46 NORTH AMERICA: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 47 EUROPE: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 48 ASIA PACIFIC: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 49 LATIN AMERICA: OTHER MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
8 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY 91
8.1 INTRODUCTION 92
TABLE 50 MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 92
8.2 SEQUENCING BY SYNTHESIS (SBS) 92
8.2.1 SBS TECHNOLOGY ENABLES HIGHEST PRODUCTION OF BASE PAIRS IN SHORT TIME 92
TABLE 51 MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY REGION, 2021–2028 (USD MILLION) 93
TABLE 52 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 53 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION) 93
TABLE 54 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 55 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBS, BY COUNTRY, 2021–2028 (USD MILLION) 94
8.3 SEQUENCING BY LIGATION (SBL) 94
8.3.1 INCREASING DEMAND FOR SBL IN FOOD MICROBIOME RESEARCH TO BOOST GROWTH 94
TABLE 56 MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 57 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 58 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 59 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 60 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR SBL, BY COUNTRY, 2021–2028 (USD MILLION) 96
8.4 NANOPORE SEQUENCING 96
8.4.1 ONLY SEQUENCING TECHNOLOGY WITH DIRECT RNA SEQUENCING CAPABILITIES 96
TABLE 61 MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 62 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 63 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 64 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 65 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021–2028 (USD MILLION) 98
8.5 OTHER TECHNOLOGIES 99
TABLE 66 MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 67 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 68 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 69 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 70 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 100
9 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER 101
9.1 INTRODUCTION 102
TABLE 71 MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 102
9.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 102
9.2.1 ROBUST FUNDING FOR MICROBIOME-BASED THERAPEUTICS TO DRIVE MARKET 102
TABLE 72 MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 73 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 103
TABLE 74 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 75 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 76 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
9.3 ACADEMIC AND RESEARCH INSTITUTES 105
9.3.1 EXPANDING APPLICATIONS OF MICROBIOME RESEARCH TO DRIVE GROWTH 105
TABLE 77 MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 105
TABLE 78 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 79 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 80 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 106
TABLE 81 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 107
9.4 OTHER END USERS 107
TABLE 82 MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 108
TABLE 83 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 84 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 85 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 86 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 109
10 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION 110
10.1 INTRODUCTION 111
FIGURE 25 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 111
TABLE 87 MICROBIOME SEQUENCING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 112
10.2 NORTH AMERICA 112
FIGURE 26 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT 113
TABLE 88 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 89 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 114
TABLE 90 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 91 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 115
TABLE 92 NORTH AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing awareness of microbiome research to drive growth 115
TABLE 93 US: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 116
TABLE 94 US: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 95 US: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 117
TABLE 96 US: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 117
10.2.2 CANADA 117
10.2.2.1 Increasing prevalence of chronic diseases to boost microbiome research 117
TABLE 97 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 118
TABLE 98 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 99 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 119
TABLE 100 CANADA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 119
10.2.3 NORTH AMERICA: IMPACT OF RECESSION 119
10.3 EUROPE 120
TABLE 101 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 102 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 121
TABLE 103 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 104 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 122
TABLE 105 EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 122
10.3.1 GERMANY 122
10.3.1.1 Rapidly increasing government funding to support growth 122
TABLE 106 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 123
TABLE 107 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 108 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 124
TABLE 109 GERMANY: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 124
10.3.2 UK 124
10.3.2.1 Significant government investments in genomics research to propel growth 124
TABLE 110 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 125
TABLE 111 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 112 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 126
TABLE 113 UK: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 126
10.3.3 FRANCE 126
10.3.3.1 Growing number of microbiome sequencing startups to propel growth 126
TABLE 114 HUMAN MICROBIOME STARTUPS IN FRANCE 127
TABLE 115 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 127
TABLE 116 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 117 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 128
TABLE 118 FRANCE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 128
10.3.4 ITALY 129
10.3.4.1 Increasing use of microbiome services in clinical research to drive growth 129
TABLE 119 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 129
TABLE 120 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 121 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 130
TABLE 122 ITALY: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 130
10.3.5 SPAIN 131
10.3.5.1 Increasing prevalence of chronic diseases to drive market 131
TABLE 123 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 131
TABLE 124 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 125 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 132
TABLE 126 SPAIN: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 132
10.3.6 REST OF EUROPE 132
TABLE 127 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 133
TABLE 128 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 129 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 133
TABLE 130 REST OF EUROPE: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 134
10.3.7 EUROPE: IMPACT OF RECESSION 134
10.4 ASIA PACIFIC 135
FIGURE 27 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET SNAPSHOT 136
TABLE 131 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
TABLE 132 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 137
TABLE 133 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 134 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 138
TABLE 135 ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 138

10.4.1 CHINA 138
10.4.1.1 Increasing investments in R&D to drive growth 138
TABLE 136 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 139
TABLE 137 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 138 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 140
TABLE 139 CHINA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 140
10.4.2 JAPAN 140
10.4.2.1 Significant growth in geriatric population to present opportunities for market growth 140
TABLE 140 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 141
TABLE 141 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
TABLE 142 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 142
TABLE 143 JAPAN: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 142
10.4.3 INDIA 142
10.4.3.1 Increasing prevalence of chronic diseases to support growth 142
TABLE 144 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 143
TABLE 145 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 146 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 144
TABLE 147 INDIA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 144
10.4.4 REST OF ASIA PACIFIC 144
TABLE 148 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 145
TABLE 149 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 150 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145
TABLE 151 REST OF ASIA PACIFIC: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.4.5 ASIA PACIFIC: IMPACT OF RECESSION 146
10.5 LATIN AMERICA 146
TABLE 152 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 147
TABLE 153 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 147
TABLE 154 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 155 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 148
TABLE 156 LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.5.1 BRAZIL 149
10.5.1.1 Growing adoption of next-generation sequencing technologies to propel growth 149
TABLE 157 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 149
TABLE 158 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 159 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 150
TABLE 160 BRAZIL: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 150
10.5.2 REST OF LATIN AMERICA 150
TABLE 161 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 151
TABLE 162 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 151
TABLE 163 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 151
TABLE 164 REST OF LATIN AMERICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 152
10.5.3 LATIN AMERICA: IMPACT OF RECESSION 152
10.6 MIDDLE EAST & AFRICA 153
TABLE 165 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY SERVICE, 2021–2028 (USD MILLION) 153
TABLE 166 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 153
TABLE 167 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 154
TABLE 168 MIDDLE EAST & AFRICA: MICROBIOME SEQUENCING SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 154
10.6.1 MIDDLE EAST & AFRICA: IMPACT OF RECESSION 154
11 COMPETITIVE LANDSCAPE 155
11.1 OVERVIEW 155
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 156
FIGURE 28 STRATEGIES ADOPTED BY KEY PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020–2023 156
11.3 MARKET SHARE ANALYSIS 157
FIGURE 29 MICROBIOME SEQUENCING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 157
TABLE 169 MICROBIOME SEQUENCING SERVICES MARKET: DEGREE OF COMPETITION 157
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 158
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MICROBIOME SEQUENCING SERVICES MARKET, 2020–2022 158
11.5 COMPANY EVALUATION QUADRANT 159
11.5.1 STARS 159
11.5.2 EMERGING LEADERS 159
11.5.3 PERVASIVE PLAYERS 159
11.5.4 PARTICIPANTS 159
FIGURE 31 MICROBIOME SEQUENCING SERVICES MARKET: COMPANY EVALUATION QUADRANT, 2022 160
11.6 COMPETITIVE SCENARIO 161
TABLE 170 SERVICE LAUNCHES 161
TABLE 171 DEALS 161
12 COMPANY PROFILES 163
12.1 KEY PLAYERS 163
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 CHARLES RIVER LABORATORIES 163
TABLE 172 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW 163
FIGURE 32 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2022) 164
12.1.2 EUROFINS SCIENTIFIC 166
TABLE 173 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 166
FIGURE 33 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022) 166
12.1.3 BGI GROUP 168
TABLE 174 BGI GROUP: BUSINESS OVERVIEW 168
12.1.4 COSMOSID 169
TABLE 175 COSMOSID: BUSINESS OVERVIEW 169
12.1.5 MICROBA 171
TABLE 176 MICROBA: BUSINESS OVERVIEW 171
12.1.6 QIAGEN N.V. 173
TABLE 177 QIAGEN N.V.: BUSINESS OVERVIEW 173
FIGURE 34 QIAGEN N.V.: COMPANY SNAPSHOT (2022) 174
12.1.7 MICROBIOME INSIGHTS 176
TABLE 178 MICROBIOME INSIGHTS: BUSINESS OVERVIEW 176
12.1.8 BASECLEAR 178
TABLE 179 BASECLEAR: BUSINESS OVERVIEW 178
12.1.9 CD GENOMICS 179
TABLE 180 CD GENOMICS: COMPANY OVERVIEW 179
12.1.10 ZYMO RESEARCH CORPORATION 181
TABLE 181 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW 181
12.1.11 ORASURE TECHNOLOGIES 183
TABLE 182 ORASURE TECHNOLOGIES: BUSINESS OVERVIEW 183
FIGURE 35 ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2022) 184
12.1.12 MR DNA 186
TABLE 183 MR DNA: BUSINESS OVERVIEW 186
12.1.13 EREMID GENOMIC SERVICES 187
TABLE 184 EREMID GENOMIC SERVICES: BUSINESS OVERVIEW 187
12.1.14 CLINICAL-MICROBIOMICS A/S 188
TABLE 185 CLINICAL-MICROBIOMICS A/S: BUSINESS OVERVIEW 188
12.1.15 NOVOGENE CO., LTD. 190
TABLE 186 NOVOGENE CO., LTD.: BUSINESS OVERVIEW 190
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 191
12.2.1 EZBIOME 191
12.2.2 BOSTER BIOLOGICAL TECHNOLOGY 191
12.2.3 ZIFO 192
12.2.4 OMICS2VIEW.CONSULTING GBR 192
12.2.5 MACROGEN, INC. 193
13 APPENDIX 194
13.1 DISCUSSION GUIDE 194
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 197
13.3 CUSTOMIZATION OPTIONS 199
13.4 RELATED REPORTS 199
13.5 AUTHOR DETAILS 200



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ マイクロバイオームシーケンスサービスの世界市場予測（～2028年）：サービス別、種類別、技術別、エンドユーザー別(Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome Sequencing), Technology (Sequencing by Synthesis, Nanopore Sequencing), End User - Global Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • プロテオミクスの世界市場予測（～2028年）：製品別、試薬別、サービス別、用途別、エンドユーザー別
  • バイオバンクの世界市場予測（～2028年）：製品/サービス別、サンプル別、所有別、用途別、エンドユーザー別
  • NGSベースRNAシーケンシングの世界市場予測（～2027）：製品＆サービス別、技術別、アプリケーション別、エンドユーザー別、地域別
  • 世界の次世代シーケンサー（NGS）市場：製品＆サービス別（消耗品、プラットフォーム、サービス）、技術別、用途別、エンドユーザー別

    • ◆H&Iグローバルリサーチのお客様（例）◆